FLGT

Fulgent Genetics, Inc. Common Stock

20.10

USD

+0.29

+1.44%

Oct 19, 10:51 UTC -4

Open

FLGT Earnings Reports

Positive Surprise Ratio

FLGT beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report

Nov 05, 2026

Estimate for Q3 26 (Revenue/ EPS)

$88.03M

-$0.66

Implied change from Q2 26 (Revenue/ EPS)

+3.09%

+15.79%

Implied change from Q3 25 (Revenue/ EPS)

+4.71%

-571.43%

Fulgent Genetics, Inc. Common Stock earnings per share and revenue

On Jul 30, 2026, FLGT reported earnings of -0.57 USD per share (EPS) for Q2 26, missing the estimate of -0.46 USD, resulting in a -23.61% surprise. Revenue reached 85.39 million, compared to an expected 95.88 million, with a -10.94% difference. The market reacted with a -18.11% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.66 USD, with revenue projected to reach 88.03 million USD, implying an increase of 15.79% EPS, and increase of 3.09% in Revenue from the last quarter.

FAQ

What were Fulgent Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Fulgent Genetics, Inc. Common Stock reported EPS of -$0.57, missing estimates by -23.61%, and revenue of $85.39M, -10.94% below expectations.

How did the market react to Fulgent Genetics, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -18.11%, changed from $20.21 before the earnings release to $16.55 the day after.

When is Fulgent Genetics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 05, 2026.

What are the forecasts for Fulgent Genetics, Inc. Common Stock's next earnings report?

Based on 5 analysts, Fulgent Genetics, Inc. Common Stock is expected to report EPS of -$0.66 and revenue of $88.03M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.